Heena M Contractor, MD
Nephrology · Los Alamitos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Medicine and Nephrology Associates · 7 clinicians in this group
Looking this up.
Hospitals listed: Coast Plaza Hospital · La Palma Intercommunity Hospital · Uci Health-Lakewood · Uci Health-Orange · West Anaheim Medical Center · 055984 · 056010 · 555070 · 555718. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Contractor’s office at (562) 596-1667 to ask if they take your plan before you enroll.
California Medical Board record
Licence A85844 · Current
Licensed to practise in California · since 2004 · expires 2028-02-29 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Coast Plaza HospitalNorwalk, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Pipeline Health, which runs 7 hospitals in 3 statesPatients rate it 1 of 5 · 41% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.3, Oct 2024 – Sep 2025
- La Palma Intercommunity HospitalLa Palma, CAAcute Care Hospital · Proprietary · No emergency departmentPart of Prime Healthcare Services, which runs 45 hospitals in 14 statesPatients rate it 2 of 5 · 55% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.151, Oct 2024 – Sep 2025
- Uci Health-LakewoodLakewood, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 1 of 5 · 48% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.105, Oct 2024 – Sep 2025
- Uci Health-OrangeOrange, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Chao Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.44 (3.82 to 7.06) · 2,934 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 82.98 (46.2 to 119.76) · 170 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.422, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.56, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.547, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.356, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.449, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 1,287 cases, Jan 2024 – Dec 2024
- West Anaheim Medical CenterAnaheim, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Prime Healthcare Services, which runs 45 hospitals in 14 statesPatients rate it 2 of 5 · 57% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.064, Oct 2024 – Sep 2025
See every measure and the patient survey for Coast Plaza Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.3 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.46 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 185 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.8 · 432 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,210 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.52) · 1,201 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (0.76 to 5.93) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.58 to 4.03) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 1.29) · 1,080 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.575 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 123 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 19.2 · 63 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 21 · 201 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 268 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 43 cases | None | Jul 2023 – Jun 2025 |
What patients said (119 patients answered, 9% of those asked)
| Cleanliness | 1 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 57% |
| Nurses "always" communicated well | 52% |
| Doctors "always" communicated well | 55% |
| Staff "always" explained | 38% |
| Yes, staff "did" give patients this information | 71% |
| Yes, staff "did" give patients information about help after discharge | 64% |
| Doctors "always" explained things so they could understand | 50% |
| Doctors "always" listened carefully | 55% |
| Doctors "always" treated them with courtesy and respect | 62% |
| Patients who gave a rating of "9" or "10" (high) | 42% |
| Staff "always" explained new medications | 48% |
| Nurses "always" explained things so they could understand | 45% |
| Nurses "always" listened carefully | 51% |
| Nurses "always" treated them with courtesy and respect | 59% |
| "Always" quiet at night | 28% |
| "YES", patients would definitely recommend the hospital | 41% |
| Staff "always" explained possible side effects | 29% |
| Yes, staff "did" give patients information about possible symptoms | 78% |
See every measure and the patient survey for La Palma Intercommunity Hospital
Behind the star rating — Deaths: 1 better, 4 the same, 0 worse of 5 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 1 better, 4 the same, 0 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.151 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 268 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.44 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.4 · 151 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 892 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,714 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,680 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.17 (0.65 to 5.68) · 137 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.55 to 3.97) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.22) · 1,314 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 44 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 139 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 87 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.4 · 159 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 228 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.5) · 31 cases | No different | Jan 2022 – Dec 2024 |
What patients said (390 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 1 |
| Communication about medicines | 2 |
| Discharge information | 1 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 73% |
| Yes, staff "did" give patients information about help after discharge | 70% |
| Doctors "always" explained things so they could understand | 61% |
| Doctors "always" listened carefully | 62% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 76% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 55% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 77% |
See every measure and the patient survey for Uci Health-Lakewood
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.105 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 512 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.77 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.76 (139.14 to 246.38) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 264 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.5 · 223 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,866 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.51) · 3,098 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,262 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.33 to 6.11) · 498 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.91 (1.29 to 4.53) · 492 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.25 (1.53 to 20.97) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.91 (0.24 to 1.58) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.584 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.498 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.265 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 181 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 403 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.3 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 89.6 · 289 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.5) · 95 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 80 cases | No different | Jan 2024 – Dec 2024 |
What patients said (391 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 78% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 49% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 60% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 48% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 80% |
See every measure and the patient survey for Uci Health-Orange
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.44 (3.82 to 7.06) · 2,934 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 82.98 (46.2 to 119.76) · 170 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.422 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.56 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.547 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.356 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 1,287 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.25 to 1.87) · 2,297 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.67 to 1.13) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 59 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 104 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 331 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 416 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 330 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,269 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.33) · 8,263 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.37) · 8,703 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.95 (0.57 to 3.32) · 1,647 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (1.33 to 3.71) · 2,756 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.15 (2.82 to 11.48) · 1,643 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.78 (2.24 to 7.33) · 1,680 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.98 (0.61 to 3.36) · 871 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.28 (0 to 0.77) · 7,232 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 170 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.546 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 165 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 556 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 75.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0 · 391 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.4 · 436 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 556 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.6) · 846 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.8 (10 to 14) · 846 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.9 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 110 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.6 to 13.8) · 2,457 cases | No different | Jan 2022 – Dec 2024 |
What patients said (575 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for West Anaheim Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 4 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.064 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.96) · 557 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.42 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.47 (138.32 to 242.62) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.5 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 67 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 121 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16 · 43 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 1,918 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 3,521 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,582 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.23 (0.86 to 5.6) · 351 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.14 (0.48 to 3.8) · 313 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.73) · 2,948 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.723 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.319 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.479 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.6 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 229 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.4 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.3 · 141 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 49.6 · 532 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.5 · 656 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 107 cases | None | Jul 2023 – Jun 2025 |
What patients said (454 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 67% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 76% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 65% |
| Doctors "always" treated them with courtesy and respect | 74% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 62% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 62% |
| Nurses "always" treated them with courtesy and respect | 76% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 57% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$2,540,431
Medicare paid this office $2,540,431 for 875 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Helicoll, per square centimeter | 13 | $2,044,699 | $1,179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 698 | $411,110 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 173 | $24,118 | $130 |
| Long return visit (40+ min) | 74 | $18,371 | $126 |
| Hospital discharge day management, more than 30 minutes | 77 | $7,032 | $87 |
See all 12 services
| Helicoll, per square centimeter | 13 | $2,044,699 | $1,179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 698 | $411,110 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 173 | $24,118 | $130 |
| Long return visit (40+ min) | 74 | $18,371 | $126 |
| Hospital discharge day management, more than 30 minutes | 77 | $7,032 | $87 |
| Return visit (30+ min) | 30 | $3,559 | $91 |
| Hemodialysis procedure with physician evaluation | 35 | $3,132 | $53 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 80 | $2,087 | $12 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 40 | $2,009 | $31 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 26 | $1,487 | $57 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 11 | $1,049 | $58 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $977 | $61 |
Who their Medicare patients are
875 Original Medicare patients in 2024. Average age 75 · Under 65 15% · 85 and older 22% · Women 51% · Also on Medicaid 71% · Health risk score 4.23. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 73% · Diabetes 66% · Heart failure 61% · Coronary heart disease 51% · Depression 49% · Dementia 42% · Atrial fibrillation 41% · COPD 40% · Stroke 35% · Cancer 14%.
The office billed $4,123,231, Medicare allowed $3,202,310 and paid $2,540,431; for 7,444 services of 53 kinds; $2,045,400 of it was for drugs given in the office and $495,031 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 875 | 7,444 | 75 | 4.23 | $4,123,231 | $2,540,431 |
| 2023 | 530 | 6,604 | 75 | 4.47 | $3,597,670 | $2,506,727 |
| 2022 | 618 | 7,856 | 75 | 3.75 | $3,055,620 | $2,196,481 |
| 2021 | 612 | 6,242 | 74 | 3.53 | $1,012,143 | $622,678 |
| 2020 | 670 | 5,517 | 74 | 4.24 | $922,636 | $492,253 |
| 2019 | 713 | 4,806 | 73 | 4.41 | $837,828 | $439,017 |
| 2018 | 679 | 4,994 | 74 | 4.45 | $837,065 | $435,580 |
| 2017 | 665 | 4,865 | 75 | 4.04 | $711,916 | $386,627 |
| 2016 | 618 | 4,598 | 74 | 4.34 | $605,056 | $331,860 |
| 2015 | 707 | 5,834 | 74 | 4.44 | $744,850 | $418,803 |
| 2014 | 645 | 5,688 | 74 | 4.23 | $675,720 | $372,594 |
| 2013 | 697 | 5,847 | 74 | 4.08 | $678,968 | $361,796 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 436 | $351,002 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $12,938 | $149 |
| Long return visit (40+ min) | 42 | $10,265 | $156 |
| Return visit (30+ min) | 52 | $9,444 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $5,427 | $68 |
| Short return visit (20+ min) | 20 | $1,671 | $64 |
2022: 7 services
| Helicoll, per square centimeter | 22 | $1,790,512 | $527 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 510 | $352,996 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $18,951 | $171 |
| Return visit (30+ min) | 58 | $9,411 | $111 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 18 | $4,388 | $137 |
| Long return visit (40+ min) | 21 | $3,878 | $149 |
| Short return visit (20+ min) | 40 | $3,454 | $72 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 524 | $315,767 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $18,991 | $174 |
| Long return visit (40+ min) | 54 | $18,739 | $160 |
| Return visit (30+ min) | 17 | $2,625 | $114 |
| Short return visit (20+ min) | 17 | $855 | $47 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 578 | $437,788 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $25,457 | $178 |
| Long return visit (40+ min) | 63 | $15,242 | $120 |
| Long return visit (40+ min) | 15 | $4,943 | $97 |
| New patient visit (60+ min) | 12 | $1,616 | $135 |
| Return visit (30+ min) | 14 | $1,540 | $96 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 599 | $380,677 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $22,299 | $174 |
| Long return visit (40+ min) | 75 | $21,176 | $123 |
| Long return visit (40+ min) | 16 | $4,213 | $96 |
| Return visit (30+ min) | 20 | $2,409 | $93 |
| New patient visit (60+ min) | 14 | $2,028 | $145 |
| New patient visit (60+ min) | 12 | $2,025 | $169 |
2018: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 565 | $355,545 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $27,249 | $172 |
| Long return visit (40+ min) | 61 | $22,483 | $124 |
| Hemodialysis procedure with physician evaluation | 67 | $10,988 | $62 |
| Hospital discharge day management, more than 30 minutes | 59 | $5,745 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $3,035 | $62 |
| Return visit (30+ min) | 26 | $3,011 | $91 |
| New patient visit (60+ min) | 16 | $2,290 | $143 |
2017: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 513 | $212,636 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 275 | $105,910 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 130 | $25,629 | $172 |
| Return visit (30+ min) | 54 | $13,719 | $93 |
| Hemodialysis procedure with physician evaluation | 55 | $10,714 | $61 |
| Hospital discharge day management, more than 30 minutes | 74 | $8,051 | $93 |
| Long return visit (40+ min) | 23 | $4,805 | $126 |
| Influenza vaccine split virus, preservative free | 13 | $625 | $48 |
| Administration of influenza virus vaccine | 13 | $380 | $29 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 11 | $159 | $11 |
| Insertion of needle into vein for collection of blood sample | 15 | $71 | $3 |
| Red blood cell concentration measurement | 11 | $45 | $3 |
| Urinalysis, manual test | 11 | $41 | $3 |
2016: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 445 | $171,107 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 256 | $100,080 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $22,804 | $169 |
| Return visit (30+ min) | 54 | $12,114 | $86 |
| Hemodialysis procedure with physician evaluation | 69 | $10,745 | $60 |
| Hospital discharge day management, more than 30 minutes | 73 | $7,399 | $90 |
| Complete ultrasound study of arm and leg arteries | 11 | $1,419 | $129 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 17 | $361 | $11 |
| Insertion of needle into vein for collection of blood sample | 47 | $226 | $3 |
| Urinalysis, manual test | 22 | $133 | $3 |
| Red blood cell concentration measurement | 17 | $101 | $3 |
2015: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 448 | $185,874 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 442 | $158,653 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 122 | $27,161 | $173 |
| Hemodialysis procedure with physician evaluation | 95 | $15,532 | $62 |
| Return visit (30+ min) | 53 | $15,229 | $92 |
| Hospital discharge day management, more than 30 minutes | 90 | $9,516 | $92 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 16 | $467 | $11 |
| Influenza vaccine split virus, preservative free | 11 | $391 | $36 |
| Administration of influenza virus vaccine | 12 | $351 | $29 |
| Insertion of needle into vein for collection of blood sample | 42 | $256 | $3 |
| Creatinine level to test for kidney function or muscle injury | 20 | $179 | $7 |
| Urinalysis, manual test | 35 | $174 | $3 |
| Red blood cell concentration measurement | 16 | $130 | $3 |
2014: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 525 | $255,716 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 299 | $49,777 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $26,750 | $171 |
| Return visit (30+ min) | 62 | $14,235 | $86 |
| Hemodialysis procedure with physician evaluation | 79 | $10,448 | $61 |
| Hospital discharge day management, more than 30 minutes | 78 | $8,835 | $91 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,342 | $61 |
| Influenza vaccine split virus, preservative free | 16 | $519 | $32 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 19 | $464 | $11 |
| Administration of influenza virus vaccine | 16 | $459 | $29 |
| Insertion of needle into vein for collection of blood sample | 35 | $203 | $3 |
| Creatinine level to test for kidney function or muscle injury | 14 | $152 | $7 |
| Red blood cell concentration measurement | 19 | $127 | $3 |
| Urinalysis, manual test | 15 | $89 | $3 |
2013: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 559 | $247,888 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 289 | $36,579 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 145 | $29,022 | $166 |
| Hemodialysis procedure with physician evaluation | 82 | $14,991 | $59 |
| Return visit (30+ min) | 57 | $14,558 | $85 |
| Hospital discharge day management, more than 30 minutes | 95 | $9,624 | $89 |
| Complete ultrasound study of arm and leg arteries | 11 | $1,506 | $137 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 31 | $879 | $11 |
| Influenza vaccine split virus, preservative free | 13 | $405 | $31 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $371 | $18 |
| Administration of influenza virus vaccine | 12 | $353 | $29 |
| Creatinine level to test for kidney function or muscle injury | 20 | $287 | $7 |
| Red blood cell concentration measurement | 31 | $251 | $3 |
| Insertion of needle into vein for collection of blood sample | 33 | $231 | $3 |
| Urinalysis, manual test | 24 | $131 | $3 |
| Blood glucose (sugar) level | 14 | $102 | $5 |
Medicaid work
$49,291 in 2024
Medicaid paid $49,291 for 1,883 billed services this clinician did in 2024, up to 68 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,843 | $46,840 |
| 1ST HOSP IP/OBS HIGH 75 | 40 | $2,451 |
| 2024 | 1,883 | 2 | 68 | $49,291 |
| 2023 | 1,820 | 1 | 51 | $54,230 |
| 2022 | 2,291 | 1 | 45 | $71,637 |
| 2021 | 1,450 | 1 | 37 | $51,931 |
| 2020 | 1,964 | 2 | 38 | $54,418 |
| 2019 | 1,255 | 2 | 37 | $28,330 |
| 2018 | 1,047 | 1 | 34 | $17,365 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,820 | $54,230 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 2,291 | $71,637 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,450 | $51,931 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,939 | $53,054 |
| 1ST HOSP IP/OBS HIGH 75 | 25 | $1,364 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,243 | $28,330 |
| Long return visit (40+ min) | 12 | $0 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,047 | $17,365 |
Drugs they prescribed that Part D paid
$480,493
Pharmacies billed $480,493 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (137 of 6,287) in 2024. A higher opioid share than 9 in 10 peers; the typical nephrology clinician is at 0%.
5,370 generic and 860 brand-name prescriptions · $480,493 in drug cost · 184 antibiotic prescriptions to 91 people · 40 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 234 | $101,383 | $433 |
| Xphozah | 13 | $38,014 | $2,924 |
| Januvia | 30 | $33,073 | $1,102 |
| Sevelamer | 45 | $20,939 | $465 |
| Jardiance | 21 | $17,321 | $825 |
See all 126 drugs
| Eliquis | 234 | $101,383 | $433 |
| Xphozah | 13 | $38,014 | $2,924 |
| Januvia | 30 | $33,073 | $1,102 |
| Sevelamer | 45 | $20,939 | $465 |
| Jardiance | 21 | $17,321 | $825 |
| Lidocaine | 62 | $9,038 | $146 |
| Multaq | 12 | $7,001 | $583 |
| Vascepa | 32 | $5,661 | $177 |
| Santyl | 16 | $4,882 | $305 |
| Sevelamer Carbonate | 32 | $4,694 | $147 |
| Basaglar Kwikpen U-100 | 15 | $4,251 | $283 |
| Symbicort | 17 | $3,853 | $227 |
| Pantoprazole | 87 | $3,480 | $40 |
| Midodrine | 38 | $3,291 | $87 |
| Atorvastatin | 316 | $2,832 | $9 |
| Levothyroxine | 256 | $2,802 | $11 |
| Nystatin-Triamcinolone | 15 | $2,735 | $182 |
| Lantus Solostar | 36 | $2,693 | $75 |
| Advair Diskus | 11 | $2,478 | $225 |
| Memantine | 78 | $2,235 | $29 |
| Albuterol Sulfate Hfa | 61 | $2,108 | $35 |
| Hydralazine | 120 | $1,937 | $16 |
| Calcium Acetate | 26 | $1,922 | $74 |
| Losartan | 175 | $1,852 | $11 |
| Insulin Lispro Kwikpen U-100 | 27 | $1,825 | $68 |
| Humulin R | 39 | $1,794 | $46 |
| Fluocinonide | 14 | $1,738 | $124 |
| Gabapentin | 143 | $1,654 | $12 |
| Megestrol Acetate | 19 | $1,635 | $86 |
| Hydrocodone-Acetaminophen | 64 | $1,592 | $25 |
| Amlodipine Besylate | 236 | $1,374 | $6 |
| Fluticasone-Salmeterol | 13 | $1,373 | $106 |
| Duloxetine | 51 | $1,358 | $27 |
| Oseltamivir Phosphate | 22 | $1,317 | $60 |
| Furosemide | 178 | $1,100 | $6 |
| Diclofenac | 30 | $1,055 | $35 |
| Nano 2nd Gen Pen Needle | 14 | $1,025 | $73 |
| Tamsulosin | 86 | $983 | $11 |
| Metoprolol | 61 | $879 | $14 |
| Potassium Chloride | 41 | $868 | $21 |
| Oxcarbazepine | 15 | $815 | $54 |
| Fenofibrate | 15 | $791 | $53 |
| Baclofen | 22 | $780 | $35 |
| Metoprolol | 104 | $776 | $7 |
| Donepezil | 86 | $763 | $9 |
| Pregabalin | 23 | $763 | $33 |
| Latanoprost | 60 | $757 | $13 |
| Famotidine | 85 | $741 | $9 |
| Enoxaparin | 17 | $719 | $42 |
| Mirtazapine | 49 | $711 | $15 |
| Acetylcysteine | 11 | $690 | $63 |
| Carvedilol | 84 | $686 | $8 |
| Carbidopa-Levodopa | 19 | $684 | $36 |
| Calcitriol | 62 | $653 | $11 |
| Rosuvastatin | 30 | $644 | $21 |
| Comfort Ez Insulin | 13 | $635 | $49 |
| Allopurinol | 90 | $621 | $7 |
| Metformin | 61 | $600 | $10 |
| Finasteride | 61 | $580 | $10 |
| Escitalopram | 66 | $572 | $9 |
| Clopidogrel | 61 | $551 | $9 |
| Humulin N | 13 | $551 | $42 |
| Ezetimibe | 29 | $515 | $18 |
| Kapspargo Sprinkle | 13 | $503 | $39 |
| Omeprazole | 53 | $495 | $9 |
| Sertraline | 42 | $492 | $12 |
| Clonidine | 53 | $474 | $9 |
| Pravastatin | 52 | $467 | $9 |
| Prednisone | 55 | $464 | $8 |
| Sodium Chloride | 17 | $455 | $27 |
| Lorazepam | 53 | $451 | $9 |
| Ipratropium-Albuterol | 13 | $444 | $34 |
| Montelukast | 42 | $444 | $11 |
| Nystatin | 14 | $425 | $30 |
| Permethrin | 12 | $402 | $33 |
| Carisoprodol | 12 | $397 | $33 |
| Tramadol | 51 | $395 | $8 |
| Lisinopril | 87 | $393 | $5 |
| Lansoprazole | 28 | $389 | $14 |
| Acetaminophen-Codeine | 17 | $389 | $23 |
| Digoxin | 23 | $387 | $17 |
| Isosorbide Mononitrate Er | 23 | $381 | $17 |
| Amiodarone | 32 | $371 | $12 |
| Nitrofurantoin Mono-Macro | 23 | $370 | $16 |
| Fluoxetine | 36 | $340 | $9 |
| Valsartan | 19 | $329 | $17 |
| Zolpidem | 42 | $310 | $7 |
| Simvastatin | 23 | $300 | $13 |
| Diltiazem 24hr Er (Cd) | 11 | $294 | $27 |
| Atenolol | 36 | $263 | $7 |
| Celecoxib | 16 | $260 | $16 |
| Glipizide Er | 19 | $254 | $13 |
| Vitamin D2 | 32 | $250 | $8 |
| Ropinirole | 13 | $248 | $19 |
| Pioglitazone | 30 | $248 | $8 |
| Ondansetron | 25 | $244 | $10 |
| Fluticasone Propionate | 19 | $221 | $12 |
| Divalproex | 23 | $216 | $9 |
| Primidone | 13 | $207 | $16 |
| Spironolactone | 27 | $206 | $8 |
| Triamcinolone Acetonide | 15 | $205 | $14 |
| Olmesartan Medoxomil | 39 | $194 | $5 |
| Quetiapine | 21 | $192 | $9 |
| Ibuprofen | 15 | $192 | $13 |
| Alendronate | 23 | $182 | $8 |
| Glipizide | 31 | $172 | $6 |
| Doxazosin Mesylate | 12 | $172 | $14 |
| Levetiracetam | 19 | $170 | $9 |
| Clotrimazole-Betamethasone | 11 | $167 | $15 |
| Doxycycline Hyclate | 17 | $164 | $10 |
| Fluconazole | 11 | $158 | $14 |
| Alprazolam | 28 | $155 | $6 |
| Mupirocin | 20 | $153 | $8 |
| Labetalol | 11 | $137 | $12 |
| Trazodone | 32 | $132 | $4 |
| Meclizine | 12 | $130 | $11 |
| Azithromycin | 33 | $128 | $4 |
| Buspirone | 15 | $123 | $8 |
| Chlordiazepoxide | 12 | $118 | $10 |
| Wixela Inhub | 11 | $114 | $10 |
| Cephalexin | 19 | $114 | $6 |
| Aripiprazole | 14 | $100 | $7 |
| Lovastatin | 11 | $70 | $6 |
| Ciprofloxacin | 12 | $65 | $5 |
| Levofloxacin | 11 | $44 | $4 |
| Hydrochlorothiazide | 26 | $24 | $1 |
Year by year
| 2024 | 6,287 | 378 | 2% (137) | 14% | $480,493 |
| 2023 | 6,066 | 341 | 3% (171) | 15% | $575,169 |
| 2022 | 4,038 | 270 | 2% (75) | 14% | $393,835 |
| 2021 | 3,261 | 245 | 3% (103) | 14% | $321,691 |
| 2020 | 3,223 | 267 | 3% (98) | 18% | $300,402 |
| 2019 | 2,894 | 251 | 3% (93) | 16% | $236,889 |
| 2018 | 2,308 | 208 | 5% (103) | 17% | $163,736 |
| 2017 | 2,490 | 188 | 3% (83) | 21% | $189,593 |
| 2016 | 1,871 | 182 | 4% (74) | 20% | $129,753 |
| 2015 | 1,737 | 175 | 6% (104) | 22% | $151,056 |
| 2014 | 1,879 | 149 | 4% (82) | 27% | $206,073 |
| 2013 | 2,257 | 150 | 5% (107) | 30% | $181,265 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 132 drugs
| Eliquis | 214 | $77,074 | $360 |
| Januvia | 47 | $47,257 | $1,005 |
| Santyl | 48 | $20,068 | $418 |
| Trulicity | 18 | $18,240 | $1,013 |
| Victoza 3-Pak | 11 | $15,255 | $1,387 |
| Farxiga | 16 | $13,796 | $862 |
| Sevelamer Carbonate | 43 | $13,660 | $318 |
| Lidocaine | 55 | $12,344 | $224 |
| Cinacalcet | 11 | $9,663 | $878 |
| Jardiance | 11 | $9,184 | $835 |
| Lactulose | 29 | $8,363 | $288 |
| Pantoprazole | 154 | $8,353 | $54 |
| Clinolipid | 26 | $7,604 | $292 |
| Lantus Solostar | 29 | $7,453 | $257 |
| Myrbetriq | 13 | $6,259 | $481 |
| Linzess | 11 | $5,682 | $517 |
| Vascepa | 12 | $4,598 | $383 |
| Novolog Flexpen | 14 | $4,515 | $322 |
| Memantine | 90 | $4,502 | $50 |
| Sevelamer | 11 | $4,319 | $393 |
| Nystatin-Triamcinolone | 14 | $4,224 | $302 |
| Restasis | 11 | $3,822 | $347 |
| Atorvastatin | 274 | $3,789 | $14 |
| Levothyroxine | 244 | $3,180 | $13 |
| Losartan | 176 | $2,988 | $17 |
| Fluocinonide | 13 | $2,766 | $213 |
| Gabapentin | 183 | $2,626 | $14 |
| Megestrol Acetate | 19 | $2,571 | $135 |
| Basaglar Kwikpen U-100 | 12 | $2,484 | $207 |
| Insulin Lispro Kwikpen U-100 | 37 | $2,401 | $65 |
| Fluticasone-Salmeterol | 15 | $2,355 | $157 |
| Humulin N | 14 | $2,021 | $144 |
| Fesoterodine Fumarate Er | 12 | $1,980 | $165 |
| Permethrin | 24 | $1,977 | $82 |
| Hydralazine | 88 | $1,864 | $21 |
| Hydrocodone-Acetaminophen | 88 | $1,771 | $20 |
| Xarelto | 11 | $1,685 | $153 |
| Calcium Acetate | 12 | $1,684 | $140 |
| Albuterol Sulfate Hfa | 42 | $1,512 | $36 |
| Rosuvastatin | 38 | $1,438 | $38 |
| Humulin R | 24 | $1,417 | $59 |
| Amlodipine Besylate | 168 | $1,374 | $8 |
| Metoprolol | 75 | $1,287 | $17 |
| Diclofenac | 36 | $1,273 | $35 |
| Tamsulosin | 78 | $1,176 | $15 |
| Baclofen | 36 | $1,135 | $32 |
| Furosemide | 189 | $1,098 | $6 |
| Ezetimibe | 25 | $1,073 | $43 |
| Donepezil | 86 | $1,058 | $12 |
| Esomeprazole Magnesium | 13 | $1,012 | $78 |
| Hydroxychloroquine Sulfate | 14 | $1,009 | $72 |
| Carvedilol | 78 | $985 | $13 |
| Potassium Chloride | 38 | $950 | $25 |
| Calcitriol | 44 | $931 | $21 |
| Metformin | 80 | $910 | $11 |
| Duloxetine | 35 | $884 | $25 |
| Divalproex | 38 | $879 | $23 |
| Lisinopril | 88 | $870 | $10 |
| Escitalopram | 66 | $863 | $13 |
| Enoxaparin | 11 | $840 | $76 |
| Metoprolol | 84 | $811 | $10 |
| Levetiracetam | 34 | $798 | $23 |
| Midodrine | 30 | $759 | $25 |
| Allopurinol | 60 | $753 | $13 |
| Pravastatin | 48 | $735 | $15 |
| Pregabalin | 26 | $708 | $27 |
| Amiodarone | 39 | $694 | $18 |
| Latanoprost | 37 | $689 | $19 |
| Glipizide Er | 25 | $683 | $27 |
| Oxycodone-Acetaminophen | 30 | $676 | $23 |
| Famotidine | 80 | $629 | $8 |
| Comfort Ez Insulin | 13 | $627 | $48 |
| Oxcarbazepine | 12 | $618 | $52 |
| Pioglitazone | 42 | $612 | $15 |
| Lansoprazole | 48 | $609 | $13 |
| Simvastatin | 47 | $589 | $13 |
| Sodium Chloride | 18 | $574 | $32 |
| Fenofibrate | 13 | $572 | $44 |
| Diltiazem 24hr Er (Cd) | 12 | $571 | $48 |
| Ipratropium-Albuterol | 25 | $544 | $22 |
| Clonidine | 52 | $508 | $10 |
| Sertraline | 57 | $503 | $9 |
| Fluticasone Propionate | 20 | $495 | $25 |
| Omeprazole | 29 | $488 | $17 |
| Nitrofurantoin Mono-Macro | 22 | $486 | $22 |
| Prednisone | 50 | $460 | $9 |
| Fluoxetine | 19 | $456 | $24 |
| Clopidogrel | 41 | $443 | $11 |
| Insulin Glargine Solostar | 12 | $439 | $37 |
| Amitriptyline | 17 | $438 | $26 |
| Celecoxib | 20 | $426 | $21 |
| Lorazepam | 28 | $398 | $14 |
| Mupirocin | 28 | $386 | $14 |
| Finasteride | 32 | $378 | $12 |
| Clotrimazole-Betamethasone | 13 | $373 | $29 |
| Clotrimazole | 16 | $367 | $23 |
| Digoxin | 21 | $354 | $17 |
| Olmesartan Medoxomil | 23 | $353 | $15 |
| Lamotrigine | 13 | $333 | $26 |
| Mirtazapine | 24 | $332 | $14 |
| Alendronate | 22 | $301 | $14 |
| Quetiapine | 21 | $268 | $13 |
| Zolpidem | 21 | $267 | $13 |
| Atenolol | 17 | $256 | $15 |
| Methotrexate | 14 | $254 | $18 |
| Carbamazepine | 11 | $249 | $23 |
| Ondansetron | 28 | $242 | $9 |
| Enalapril Maleate | 12 | $215 | $18 |
| Alprazolam | 20 | $211 | $11 |
| Tramadol | 32 | $211 | $7 |
| Citalopram Hbr | 21 | $191 | $9 |
| Levofloxacin | 11 | $190 | $17 |
| Glipizide | 14 | $189 | $14 |
| Buspirone | 18 | $186 | $10 |
| Primidone | 16 | $175 | $11 |
| Ropinirole | 13 | $168 | $13 |
| Montelukast | 24 | $167 | $7 |
| Spironolactone | 20 | $158 | $8 |
| Benazepril | 15 | $155 | $10 |
| Paroxetine | 12 | $148 | $12 |
| Azithromycin | 19 | $147 | $8 |
| Ibuprofen | 20 | $140 | $7 |
| Venlafaxine Hcl Er | 11 | $123 | $11 |
| Hydrochlorothiazide | 38 | $114 | $3 |
| Cephalexin | 12 | $106 | $9 |
| Trazodone | 11 | $100 | $9 |
| Pramipexole Dihydrochloride | 13 | $98 | $8 |
| Lovastatin | 13 | $87 | $7 |
| Metoclopramide | 11 | $84 | $8 |
| Fluconazole | 13 | $79 | $6 |
| Meloxicam | 11 | $67 | $6 |
| Loperamide | 15 | $31 | $2 |
2022: 93 drugs
| Januvia | 59 | $49,984 | $847 |
| Eliquis | 117 | $49,622 | $424 |
| Lactulose | 28 | $24,340 | $869 |
| Sevelamer Carbonate | 30 | $22,864 | $762 |
| Victoza 3-Pak | 13 | $14,696 | $1,130 |
| Farxiga | 17 | $13,942 | $820 |
| Restasis | 18 | $10,065 | $559 |
| Lidocaine | 41 | $9,057 | $221 |
| Basaglar Kwikpen U-100 | 27 | $8,787 | $325 |
| Novolog Flexpen | 15 | $7,781 | $519 |
| Myrbetriq | 12 | $5,562 | $463 |
| Pantoprazole | 87 | $5,386 | $62 |
| Vascepa | 12 | $4,601 | $383 |
| Lantus Solostar | 17 | $3,536 | $208 |
| Nystatin-Triamcinolone | 12 | $3,310 | $276 |
| Fluocinonide | 12 | $2,553 | $213 |
| Duloxetine | 52 | $2,298 | $44 |
| Atorvastatin | 174 | $2,283 | $13 |
| Potassium Chloride | 46 | $1,892 | $41 |
| Humulin N | 13 | $1,887 | $145 |
| Levothyroxine | 110 | $1,885 | $17 |
| Gabapentin | 121 | $1,845 | $15 |
| Diltiazem 24hr Er (Cd) | 16 | $1,806 | $113 |
| Albuterol Sulfate Hfa | 35 | $1,788 | $51 |
| Calcitriol | 62 | $1,693 | $27 |
| Losartan | 139 | $1,605 | $12 |
| Hydralazine | 103 | $1,559 | $15 |
| Fenofibrate | 15 | $1,457 | $97 |
| Fluticasone-Salmeterol | 12 | $1,407 | $117 |
| Humulin R | 12 | $1,255 | $105 |
| Memantine | 29 | $1,229 | $42 |
| Amlodipine Besylate | 137 | $1,190 | $9 |
| Pregabalin | 17 | $1,155 | $68 |
| Levetiracetam | 34 | $1,085 | $32 |
| Metoprolol | 43 | $1,065 | $25 |
| Metformin | 120 | $969 | $8 |
| Clopidogrel | 53 | $838 | $16 |
| Ezetimibe | 24 | $777 | $32 |
| Lisinopril | 94 | $773 | $8 |
| Ulticare Pen Needle | 12 | $770 | $64 |
| Furosemide | 110 | $670 | $6 |
| Nitrofurantoin Mono-Macro | 33 | $658 | $20 |
| Allopurinol | 56 | $656 | $12 |
| Ammonium Lactate | 12 | $654 | $54 |
| Escitalopram | 45 | $597 | $13 |
| Alcohol Prep Pads | 17 | $597 | $35 |
| Glipizide Er | 34 | $584 | $17 |
| Quetiapine | 50 | $580 | $12 |
| Olmesartan Medoxomil | 18 | $569 | $32 |
| Comfort Ez Insulin | 12 | $553 | $46 |
| Carvedilol | 45 | $545 | $12 |
| Diclofenac | 23 | $543 | $24 |
| Tamsulosin | 38 | $535 | $14 |
| Enoxaparin | 13 | $534 | $41 |
| Clonidine | 44 | $517 | $12 |
| Rosuvastatin | 17 | $493 | $29 |
| Simvastatin | 46 | $469 | $10 |
| Omeprazole | 25 | $466 | $19 |
| Oxcarbazepine | 13 | $442 | $34 |
| Metoprolol | 43 | $415 | $10 |
| Divalproex | 15 | $414 | $28 |
| Clotrimazole | 16 | $390 | $24 |
| Phenytoin Sodium Extended | 13 | $385 | $30 |
| Pioglitazone | 23 | $366 | $16 |
| Hydrocodone-Acetaminophen | 19 | $359 | $19 |
| Alendronate | 29 | $339 | $12 |
| Venlafaxine Hcl Er | 27 | $330 | $12 |
| Oxycodone-Acetaminophen | 39 | $310 | $8 |
| Ondansetron | 15 | $304 | $20 |
| Phenytoin | 12 | $300 | $25 |
| Pravastatin | 18 | $279 | $15 |
| Levofloxacin | 19 | $277 | $15 |
| Lansoprazole | 23 | $256 | $11 |
| Donepezil | 23 | $249 | $11 |
| Montelukast | 35 | $237 | $7 |
| Fluticasone Propionate | 18 | $234 | $13 |
| Famotidine | 31 | $221 | $7 |
| Atenolol | 30 | $210 | $7 |
| Midodrine | 13 | $187 | $14 |
| Amiodarone | 13 | $178 | $14 |
| Prednisone | 17 | $166 | $10 |
| Glipizide | 19 | $157 | $8 |
| Lorazepam | 21 | $148 | $7 |
| Mupirocin | 15 | $142 | $9 |
| Levocetirizine Dihydrochloride | 12 | $132 | $11 |
| Azithromycin | 24 | $128 | $5 |
| Cyclobenzaprine | 12 | $126 | $11 |
| Hydrochlorothiazide | 32 | $97 | $3 |
| Ibuprofen | 13 | $85 | $7 |
| Fluoxetine | 15 | $82 | $5 |
| Sertraline | 15 | $71 | $5 |
| Meloxicam | 17 | $70 | $4 |
| Metformin Hcl Er | 11 | $38 | $3 |
2021: 82 drugs
| Januvia | 67 | $54,072 | $807 |
| Lactulose | 24 | $43,273 | $1,803 |
| Eliquis | 87 | $35,977 | $414 |
| Sevelamer Carbonate | 14 | $10,180 | $727 |
| Ozempic | 11 | $9,281 | $844 |
| Lidocaine | 22 | $8,560 | $389 |
| Basaglar Kwikpen U-100 | 23 | $7,596 | $330 |
| Novolog Flexpen | 11 | $4,137 | $376 |
| Nystatin-Triamcinolone | 12 | $3,487 | $291 |
| Lantus Solostar | 12 | $3,477 | $290 |
| Levemir Flextouch | 11 | $3,457 | $314 |
| Fluocinonide | 12 | $2,553 | $213 |
| Atorvastatin | 144 | $2,160 | $15 |
| Pregabalin | 19 | $1,914 | $101 |
| Rosuvastatin | 25 | $1,873 | $75 |
| Metoprolol | 58 | $1,789 | $31 |
| Humulin N | 12 | $1,742 | $145 |
| Levothyroxine | 93 | $1,718 | $18 |
| Potassium Chloride | 29 | $1,563 | $54 |
| Hydrocodone-Acetaminophen | 61 | $1,467 | $24 |
| Fluticasone-Salmeterol | 12 | $1,464 | $122 |
| Pantoprazole | 63 | $1,308 | $21 |
| Albuterol Sulfate Hfa | 24 | $1,179 | $49 |
| Losartan | 93 | $1,090 | $12 |
| Amlodipine Besylate | 132 | $1,071 | $8 |
| Hydralazine | 68 | $958 | $14 |
| Calcitriol | 22 | $936 | $43 |
| Gabapentin | 97 | $932 | $10 |
| Olmesartan Medoxomil | 21 | $876 | $42 |
| Fenofibrate | 12 | $811 | $68 |
| Ezetimibe | 26 | $796 | $31 |
| Levetiracetam | 33 | $679 | $21 |
| Diclofenac | 30 | $651 | $22 |
| Metformin | 85 | $578 | $7 |
| Quetiapine | 44 | $566 | $13 |
| Omeprazole | 23 | $541 | $24 |
| Comfort Ez Insulin | 11 | $539 | $49 |
| Lisinopril | 62 | $534 | $9 |
| Simvastatin | 35 | $519 | $15 |
| Divalproex | 24 | $513 | $21 |
| Tamsulosin | 35 | $500 | $14 |
| Glipizide Er | 24 | $468 | $20 |
| Memantine | 13 | $457 | $35 |
| Allopurinol | 49 | $446 | $9 |
| Furosemide | 99 | $430 | $4 |
| Nitrofurantoin Mono-Macro | 16 | $423 | $26 |
| Clonidine | 38 | $411 | $11 |
| Alcohol Prep Pads | 13 | $401 | $31 |
| Oxcarbazepine | 12 | $395 | $33 |
| Lorazepam | 51 | $387 | $8 |
| Phenytoin Sodium Extended | 13 | $365 | $28 |
| Bupropion Xl | 13 | $343 | $26 |
| Carvedilol | 32 | $327 | $10 |
| Clopidogrel | 35 | $303 | $9 |
| Metoprolol | 32 | $270 | $8 |
| Alendronate | 20 | $266 | $13 |
| Zolpidem | 22 | $263 | $12 |
| Famotidine | 18 | $258 | $14 |
| Escitalopram | 18 | $250 | $14 |
| Lansoprazole | 25 | $239 | $10 |
| Atenolol | 27 | $235 | $9 |
| Pioglitazone | 18 | $230 | $13 |
| Mirtazapine | 16 | $227 | $14 |
| Mupirocin | 15 | $202 | $13 |
| Cyclobenzaprine | 16 | $198 | $12 |
| Montelukast | 43 | $195 | $5 |
| Triamterene-Hydrochlorothiazid | 17 | $181 | $11 |
| Glipizide | 22 | $168 | $8 |
| Alprazolam | 23 | $168 | $7 |
| Acetaminophen-Codeine | 14 | $165 | $12 |
| Duloxetine | 14 | $159 | $11 |
| Donepezil | 15 | $140 | $9 |
| Tramadol | 24 | $117 | $5 |
| Azithromycin | 13 | $113 | $9 |
| Prednisone | 15 | $92 | $6 |
| Benazepril | 12 | $91 | $8 |
| Ibuprofen | 13 | $90 | $7 |
| Fluoxetine | 13 | $89 | $7 |
| Sertraline | 14 | $69 | $5 |
| Hydrochlorothiazide | 24 | $58 | $2 |
| Meloxicam | 20 | $52 | $3 |
| Metformin Hcl Er | 12 | $28 | $2 |
2020: 82 drugs
| Eliquis | 54 | $28,055 | $520 |
| Januvia | 41 | $25,403 | $620 |
| Velphoro | 14 | $19,573 | $1,398 |
| Lidocaine | 28 | $9,471 | $338 |
| Sevelamer Carbonate | 16 | $8,237 | $515 |
| Linzess | 11 | $7,610 | $692 |
| Tradjenta | 14 | $6,401 | $457 |
| Lokelma | 17 | $5,600 | $329 |
| Levemir Flextouch | 20 | $5,565 | $278 |
| Basaglar Kwikpen U-100 | 12 | $3,736 | $311 |
| Lantus Solostar | 14 | $3,177 | $227 |
| Potassium Chloride | 39 | $3,085 | $79 |
| Nystatin-Triamcinolone | 12 | $2,877 | $240 |
| Fluocinonide | 12 | $2,553 | $213 |
| Wixela Inhub | 13 | $2,416 | $186 |
| Atorvastatin | 150 | $2,154 | $14 |
| Metoprolol | 68 | $2,061 | $30 |
| Fluticasone-Salmeterol | 12 | $1,981 | $165 |
| Levothyroxine | 89 | $1,784 | $20 |
| Humulin N | 12 | $1,746 | $145 |
| Fenofibrate | 12 | $1,386 | $116 |
| Albuterol Sulfate Hfa | 31 | $1,283 | $41 |
| Diclofenac | 43 | $1,246 | $29 |
| Hydrocodone-Acetaminophen | 50 | $1,173 | $23 |
| Gabapentin | 85 | $1,109 | $13 |
| Midodrine | 17 | $1,083 | $64 |
| Calcium Acetate | 13 | $1,078 | $83 |
| Pregabalin | 15 | $1,053 | $70 |
| Olmesartan Medoxomil | 22 | $1,042 | $47 |
| Losartan | 102 | $950 | $9 |
| Amlodipine Besylate | 129 | $923 | $7 |
| Calcitriol | 28 | $860 | $31 |
| Memantine | 11 | $773 | $70 |
| Furosemide | 101 | $740 | $7 |
| Allopurinol | 50 | $730 | $15 |
| Ezetimibe | 18 | $721 | $40 |
| Quetiapine | 28 | $706 | $25 |
| Alcohol Pads | 15 | $695 | $46 |
| Oxcarbazepine | 12 | $607 | $51 |
| Duloxetine | 14 | $583 | $42 |
| Metformin | 102 | $554 | $5 |
| Carbidopa-Levodopa | 11 | $553 | $50 |
| Lansoprazole | 24 | $487 | $20 |
| Easy Comfort Insulin | 12 | $468 | $39 |
| Omeprazole | 23 | $447 | $19 |
| Hydralazine | 27 | $437 | $16 |
| Metoprolol | 28 | $434 | $16 |
| Montelukast | 55 | $404 | $7 |
| Simvastatin | 39 | $390 | $10 |
| Cyproheptadine | 14 | $365 | $26 |
| Tamsulosin | 18 | $330 | $18 |
| Lisinopril | 57 | $330 | $6 |
| Glipizide Er | 15 | $315 | $21 |
| Levetiracetam | 28 | $312 | $11 |
| Enalapril Maleate | 23 | $307 | $13 |
| Pantoprazole | 39 | $303 | $8 |
| Ondansetron | 12 | $302 | $25 |
| Lorazepam | 40 | $281 | $7 |
| Zolpidem | 18 | $276 | $15 |
| Carvedilol | 25 | $272 | $11 |
| Pravastatin | 13 | $269 | $21 |
| Nitrofurantoin Mono-Macro | 17 | $265 | $16 |
| Bupropion Hcl Sr | 11 | $261 | $24 |
| Escitalopram | 11 | $257 | $23 |
| Venlafaxine | 11 | $235 | $21 |
| Azithromycin | 33 | $225 | $7 |
| Atenolol | 15 | $195 | $13 |
| Clonidine | 27 | $189 | $7 |
| Glipizide | 30 | $188 | $6 |
| Alendronate | 11 | $158 | $14 |
| Clopidogrel | 17 | $154 | $9 |
| Pioglitazone | 14 | $131 | $9 |
| Spironolactone | 13 | $121 | $9 |
| Alprazolam | 16 | $120 | $8 |
| Hydrochlorothiazide | 41 | $120 | $3 |
| Tramadol | 35 | $111 | $3 |
| Prednisone | 15 | $108 | $7 |
| Cyclobenzaprine | 16 | $93 | $6 |
| Sertraline | 23 | $86 | $4 |
| Meloxicam | 31 | $80 | $3 |
| Famotidine | 16 | $78 | $5 |
| Cephalexin | 13 | $70 | $5 |
2019: 75 drugs
| Eliquis | 48 | $22,442 | $468 |
| Januvia | 47 | $21,730 | $462 |
| Metformin Er Gastric | 12 | $14,684 | $1,224 |
| Sevelamer Carbonate | 24 | $11,421 | $476 |
| Sensipar | 12 | $9,851 | $821 |
| Lidocaine | 19 | $6,596 | $347 |
| Ursodiol | 12 | $4,072 | $339 |
| Humalog | 13 | $4,068 | $313 |
| Nystatin-Triamcinolone | 11 | $2,642 | $240 |
| Atorvastatin | 126 | $2,167 | $17 |
| Midodrine | 33 | $2,107 | $64 |
| Metoprolol | 57 | $2,047 | $36 |
| Potassium Chloride | 34 | $1,610 | $47 |
| Diclofenac | 22 | $1,460 | $66 |
| Levothyroxine | 71 | $1,303 | $18 |
| Gabapentin | 63 | $1,165 | $18 |
| Bumetanide | 23 | $1,080 | $47 |
| Olmesartan Medoxomil | 22 | $1,055 | $48 |
| Amlodipine Besylate | 126 | $1,004 | $8 |
| Ventolin Hfa | 17 | $953 | $56 |
| Hydrocodone-Acetaminophen | 45 | $903 | $20 |
| Hydralazine | 43 | $858 | $20 |
| Alcohol Pads | 14 | $725 | $52 |
| Losartan | 76 | $697 | $9 |
| Oxybutynin Chloride | 12 | $674 | $56 |
| Furosemide | 113 | $618 | $5 |
| Zolpidem | 19 | $554 | $29 |
| Metformin | 82 | $552 | $7 |
| Ramipril | 14 | $505 | $36 |
| Enalapril Maleate | 22 | $490 | $22 |
| Allopurinol | 35 | $451 | $13 |
| Montelukast | 36 | $449 | $12 |
| Omeprazole | 35 | $447 | $13 |
| Fenofibrate | 12 | $422 | $35 |
| Lisinopril | 49 | $398 | $8 |
| Pantoprazole | 57 | $396 | $7 |
| Digoxin | 16 | $389 | $24 |
| Levetiracetam | 21 | $370 | $18 |
| Pioglitazone | 13 | $339 | $26 |
| Simvastatin | 43 | $326 | $8 |
| Nitrofurantoin Mono-Macro | 16 | $315 | $20 |
| Buspirone | 11 | $314 | $29 |
| Azithromycin | 42 | $307 | $7 |
| Acetaminophen-Codeine | 12 | $290 | $24 |
| Metoprolol | 36 | $286 | $8 |
| Pravastatin | 12 | $278 | $23 |
| Quetiapine | 29 | $267 | $9 |
| Carvedilol | 27 | $267 | $10 |
| Levofloxacin | 18 | $249 | $14 |
| Calcitriol | 12 | $242 | $20 |
| Glipizide Er | 15 | $238 | $16 |
| Spironolactone | 14 | $231 | $17 |
| Doxycycline Hyclate | 12 | $214 | $18 |
| Trazodone | 14 | $213 | $15 |
| Dilt-Xr | 11 | $204 | $19 |
| Clopidogrel | 24 | $201 | $8 |
| Venlafaxine | 11 | $200 | $18 |
| Alprazolam | 20 | $195 | $10 |
| Benazepril | 17 | $185 | $11 |
| Famotidine | 23 | $167 | $7 |
| Glipizide | 22 | $156 | $7 |
| Atenolol | 13 | $155 | $12 |
| Hydrochlorothiazide | 38 | $148 | $4 |
| Tramadol | 31 | $132 | $4 |
| Prednisone | 25 | $130 | $5 |
| Fluticasone Propionate | 11 | $124 | $11 |
| Lorazepam | 20 | $118 | $6 |
| Mupirocin | 12 | $110 | $9 |
| Mirtazapine | 12 | $108 | $9 |
| Ciprofloxacin | 12 | $104 | $9 |
| Carisoprodol | 12 | $85 | $7 |
| Clonidine | 11 | $72 | $7 |
| Meloxicam | 22 | $70 | $3 |
| Meclizine | 11 | $68 | $6 |
| Sertraline | 12 | $37 | $3 |
2018: 63 drugs
| Procrit | 32 | $17,895 | $559 |
| Januvia | 30 | $16,308 | $544 |
| Eliquis | 13 | $7,724 | $594 |
| Flovent Hfa | 13 | $5,077 | $391 |
| Prosol | 36 | $4,798 | $133 |
| Lyrica | 11 | $3,733 | $339 |
| Ursodiol | 13 | $3,680 | $283 |
| Symbicort | 11 | $3,338 | $303 |
| Metolazone | 12 | $1,800 | $150 |
| Atorvastatin | 77 | $1,676 | $22 |
| Potassium Chloride | 34 | $1,592 | $47 |
| Levothyroxine | 72 | $1,334 | $19 |
| Hydrocodone-Acetaminophen | 51 | $1,303 | $26 |
| Isosorbide Dinitrate | 13 | $937 | $72 |
| Midodrine | 11 | $935 | $85 |
| Metoprolol | 37 | $921 | $25 |
| Diclofenac | 11 | $918 | $83 |
| Megestrol Acetate | 14 | $722 | $52 |
| Calcitriol | 22 | $682 | $31 |
| Amlodipine Besylate | 97 | $639 | $7 |
| Oxybutynin Chloride | 13 | $620 | $48 |
| Hydralazine | 33 | $585 | $18 |
| Acetaminophen-Codeine | 23 | $559 | $24 |
| Ondansetron Odt | 18 | $549 | $31 |
| Ultra-Fine Original Pen Needle | 11 | $532 | $48 |
| Furosemide | 89 | $520 | $6 |
| Oxycodone-Acetaminophen | 11 | $507 | $46 |
| Clopidogrel | 17 | $488 | $29 |
| Gabapentin | 49 | $458 | $9 |
| Lisinopril | 49 | $444 | $9 |
| Metformin | 63 | $431 | $7 |
| Losartan | 56 | $422 | $8 |
| Simvastatin | 47 | $421 | $9 |
| Pantoprazole | 51 | $400 | $8 |
| Zolpidem | 18 | $400 | $22 |
| Doxycycline Hyclate | 14 | $385 | $27 |
| Escitalopram | 11 | $336 | $31 |
| Montelukast | 27 | $334 | $12 |
| Pravastatin | 14 | $311 | $22 |
| Enalapril Maleate | 13 | $287 | $22 |
| Omeprazole | 23 | $282 | $12 |
| Carvedilol | 36 | $275 | $8 |
| Buspirone | 11 | $270 | $25 |
| Alprazolam | 36 | $260 | $7 |
| Azithromycin | 33 | $234 | $7 |
| Nitrofurantoin Mono-Macro | 14 | $230 | $16 |
| Atenolol | 23 | $227 | $10 |
| Levofloxacin | 18 | $195 | $11 |
| Lorazepam | 16 | $167 | $10 |
| Famotidine | 19 | $166 | $9 |
| Clonidine | 23 | $164 | $7 |
| Benazepril | 16 | $163 | $10 |
| Quetiapine | 16 | $148 | $9 |
| Tramadol | 16 | $143 | $9 |
| Losartan-Hydrochlorothiazide | 11 | $140 | $13 |
| Spironolactone | 15 | $137 | $9 |
| Mupirocin | 12 | $137 | $11 |
| Allopurinol | 18 | $116 | $6 |
| Hydrochlorothiazide | 22 | $91 | $4 |
| Prednisone | 15 | $82 | $5 |
| Carisoprodol | 12 | $73 | $6 |
| Cephalexin | 13 | $71 | $5 |
| Metoprolol | 18 | $71 | $4 |
2017: 70 drugs
| Procrit | 67 | $26,191 | $391 |
| Januvia | 56 | $13,798 | $246 |
| Levemir | 20 | $8,441 | $422 |
| Novolog Flexpen | 27 | $5,818 | $215 |
| Novolog | 13 | $5,346 | $411 |
| Protonix | 24 | $4,868 | $203 |
| Santyl | 21 | $4,840 | $230 |
| Ursodiol | 11 | $3,730 | $339 |
| Lyrica | 13 | $2,973 | $229 |
| Freamine III | 14 | $2,635 | $188 |
| Tradjenta | 13 | $2,492 | $192 |
| Ezetimibe | 12 | $1,494 | $125 |
| Potassium Chloride | 31 | $1,449 | $47 |
| Levothyroxine | 62 | $1,215 | $20 |
| Hydrocodone-Acetaminophen | 47 | $990 | $21 |
| Gabapentin | 65 | $886 | $14 |
| Acetylcysteine | 17 | $811 | $48 |
| Valproic Acid | 17 | $805 | $47 |
| Methenamine Hippurate | 14 | $765 | $55 |
| Valsartan | 11 | $702 | $64 |
| Calcitriol | 27 | $701 | $26 |
| Metoprolol | 28 | $583 | $21 |
| Oxybutynin Chloride | 13 | $567 | $44 |
| Gentamicin Sulfate | 12 | $547 | $46 |
| Atorvastatin | 43 | $526 | $12 |
| Ipratropium-Albuterol | 22 | $523 | $24 |
| Acetaminophen-Codeine | 20 | $499 | $25 |
| Midodrine | 11 | $479 | $44 |
| Simvastatin | 61 | $470 | $8 |
| Venlafaxine | 12 | $432 | $36 |
| Amlodipine Besylate | 82 | $411 | $5 |
| Metformin | 64 | $409 | $6 |
| Tamsulosin | 18 | $382 | $21 |
| Furosemide | 81 | $369 | $5 |
| Donepezil | 19 | $362 | $19 |
| Escitalopram | 23 | $346 | $15 |
| Allopurinol | 28 | $310 | $11 |
| Quetiapine | 28 | $308 | $11 |
| Lisinopril | 48 | $301 | $6 |
| Omeprazole | 43 | $291 | $7 |
| Pantoprazole | 46 | $283 | $6 |
| Glipizide Er | 16 | $277 | $17 |
| Alprazolam | 45 | $259 | $6 |
| Hydralazine | 20 | $248 | $12 |
| Losartan | 32 | $246 | $8 |
| Mupirocin | 16 | $220 | $14 |
| Clopidogrel | 18 | $217 | $12 |
| Amiodarone | 24 | $207 | $9 |
| Spironolactone | 19 | $206 | $11 |
| Carvedilol | 37 | $196 | $5 |
| Prednisone | 19 | $190 | $10 |
| Levofloxacin | 15 | $187 | $12 |
| Finasteride | 17 | $185 | $11 |
| Pentoxifylline | 13 | $182 | $14 |
| Pravastatin | 16 | $182 | $11 |
| Famotidine | 32 | $176 | $5 |
| Lorazepam | 14 | $163 | $12 |
| Primidone | 12 | $163 | $14 |
| Risperidone | 14 | $161 | $12 |
| Metoprolol | 26 | $152 | $6 |
| Montelukast | 13 | $142 | $11 |
| Tramadol | 15 | $139 | $9 |
| Azithromycin | 29 | $138 | $5 |
| Zolpidem | 20 | $133 | $7 |
| Glipizide | 13 | $98 | $8 |
| Hydrochlorothiazide | 13 | $91 | $7 |
| Metoclopramide | 13 | $89 | $7 |
| Meloxicam | 18 | $83 | $5 |
| Carisoprodol | 12 | $65 | $5 |
| Lisinopril-Hydrochlorothiazide | 18 | $58 | $3 |
2016: 47 drugs
| Advair Diskus | 14 | $7,209 | $515 |
| Procrit | 25 | $6,528 | $261 |
| Januvia | 16 | $5,642 | $353 |
| Potassium Chloride | 32 | $5,379 | $168 |
| Tradjenta | 28 | $5,083 | $182 |
| Zetia | 17 | $4,380 | $258 |
| Humalog | 16 | $3,873 | $242 |
| Hydrocodone-Acetaminophen | 55 | $1,963 | $36 |
| Methenamine Hippurate | 16 | $965 | $60 |
| Levothyroxine | 44 | $778 | $18 |
| Metformin | 73 | $681 | $9 |
| Simvastatin | 40 | $655 | $16 |
| Enoxaparin | 12 | $646 | $54 |
| Atorvastatin | 41 | $641 | $16 |
| Amlodipine Besylate | 83 | $525 | $6 |
| Levofloxacin | 24 | $431 | $18 |
| Lisinopril | 53 | $418 | $8 |
| Famotidine | 11 | $402 | $37 |
| Losartan | 37 | $396 | $11 |
| Tamsulosin | 28 | $387 | $14 |
| Donepezil | 25 | $360 | $14 |
| Metoprolol | 13 | $349 | $27 |
| Gabapentin | 22 | $301 | $14 |
| Omeprazole | 34 | $299 | $9 |
| Lansoprazole | 12 | $275 | $23 |
| Escitalopram | 26 | $275 | $11 |
| Pantoprazole | 36 | $270 | $7 |
| Prednisone | 24 | $259 | $11 |
| Quetiapine | 24 | $245 | $10 |
| Calcitriol | 12 | $230 | $19 |
| Furosemide | 53 | $220 | $4 |
| Lorazepam | 15 | $220 | $15 |
| Clopidogrel | 12 | $186 | $16 |
| Azithromycin | 25 | $186 | $7 |
| Glipizide | 16 | $186 | $12 |
| Gemfibrozil | 11 | $175 | $16 |
| Mupirocin | 14 | $169 | $12 |
| Metoprolol | 25 | $156 | $6 |
| Carvedilol | 21 | $155 | $7 |
| Alprazolam | 32 | $151 | $5 |
| Clonidine | 25 | $144 | $6 |
| Allopurinol | 12 | $134 | $11 |
| Atenolol | 21 | $121 | $6 |
| Primidone | 12 | $110 | $9 |
| Hydrochlorothiazide | 19 | $80 | $4 |
| Diazepam | 32 | $68 | $2 |
| Zolpidem | 28 | $43 | $2 |
2015: 47 drugs
| Procrit | 19 | $12,409 | $653 |
| Modafinil | 11 | $6,494 | $590 |
| Advair Diskus | 14 | $5,449 | $389 |
| Lyrica | 11 | $4,803 | $437 |
| Pradaxa | 13 | $4,177 | $321 |
| Tradjenta | 24 | $4,131 | $172 |
| Humalog | 16 | $3,823 | $239 |
| Januvia | 11 | $3,719 | $338 |
| Potassium Chloride | 37 | $2,255 | $61 |
| Methenamine Hippurate | 32 | $2,186 | $68 |
| Hydrocodone-Acetaminophen | 59 | $1,943 | $33 |
| Nexium | 11 | $1,826 | $166 |
| Levothyroxine | 49 | $1,103 | $23 |
| Enoxaparin | 12 | $994 | $83 |
| Levofloxacin | 30 | $966 | $32 |
| Acarbose | 12 | $926 | $77 |
| Gabapentin | 31 | $615 | $20 |
| Omeprazole | 33 | $594 | $18 |
| Atorvastatin | 39 | $550 | $14 |
| Amlodipine Besylate | 79 | $546 | $7 |
| Lorazepam | 32 | $510 | $16 |
| Simvastatin | 39 | $507 | $13 |
| Metoprolol | 14 | $506 | $36 |
| Metformin | 57 | $484 | $8 |
| Quetiapine | 18 | $432 | $24 |
| Donepezil | 15 | $420 | $28 |
| Clopidogrel | 23 | $296 | $13 |
| Furosemide | 58 | $288 | $5 |
| Enalapril Maleate | 12 | $283 | $24 |
| Atenolol | 22 | $278 | $13 |
| Metoprolol | 23 | $216 | $9 |
| Tamsulosin | 13 | $208 | $16 |
| Losartan | 22 | $205 | $9 |
| Lisinopril | 39 | $202 | $5 |
| Escitalopram | 17 | $199 | $12 |
| Zolpidem | 36 | $196 | $5 |
| Azithromycin | 25 | $181 | $7 |
| Carvedilol | 15 | $153 | $10 |
| Prednisone | 16 | $148 | $9 |
| Clonidine | 17 | $129 | $8 |
| Tramadol | 22 | $121 | $6 |
| Primidone | 12 | $120 | $10 |
| Alprazolam | 22 | $110 | $5 |
| Alendronate | 14 | $88 | $6 |
| Benazepril | 13 | $79 | $6 |
| Hydrochlorothiazide | 24 | $69 | $3 |
| Diazepam | 21 | $47 | $2 |
2014: 54 drugs
| Rilutek | 12 | $25,465 | $2,122 |
| Modafinil | 27 | $16,649 | $617 |
| Lantus | 13 | $6,935 | $533 |
| Januvia | 20 | $5,274 | $264 |
| Nexium | 28 | $4,474 | $160 |
| Novolog | 15 | $3,961 | $264 |
| Tradjenta | 26 | $3,933 | $151 |
| Advair Diskus | 13 | $3,795 | $292 |
| Humalog | 20 | $3,780 | $189 |
| Benicar | 20 | $3,750 | $188 |
| Transderm-Scop | 14 | $3,673 | $262 |
| Methenamine Hippurate | 38 | $2,569 | $68 |
| Midodrine | 18 | $2,343 | $130 |
| Hydrocodone-Acetaminophen | 62 | $2,117 | $34 |
| Proair Hfa | 13 | $1,939 | $149 |
| Potassium Chloride | 36 | $1,912 | $53 |
| Dextrose in Water | 16 | $1,808 | $113 |
| Levothyroxine | 61 | $1,067 | $17 |
| Levofloxacin | 17 | $892 | $52 |
| Acarbose | 12 | $848 | $71 |
| Amlodipine Besylate | 79 | $675 | $9 |
| Gabapentin | 19 | $582 | $31 |
| Carbidopa-Levodopa | 20 | $467 | $23 |
| Simvastatin | 41 | $438 | $11 |
| Clopidogrel | 32 | $429 | $13 |
| Metformin | 51 | $420 | $8 |
| Lorazepam | 27 | $410 | $15 |
| Metoprolol | 14 | $407 | $29 |
| Furosemide | 81 | $400 | $5 |
| Digoxin | 12 | $318 | $27 |
| Zolpidem | 28 | $281 | $10 |
| Omeprazole | 35 | $279 | $8 |
| Azithromycin | 18 | $203 | $11 |
| Carvedilol | 25 | $199 | $8 |
| Atorvastatin | 17 | $195 | $11 |
| Chlorthalidone | 12 | $192 | $16 |
| Atenolol | 23 | $172 | $7 |
| Metoprolol | 22 | $160 | $7 |
| Clonidine | 19 | $128 | $7 |
| Paroxetine | 14 | $127 | $9 |
| Lisinopril | 20 | $126 | $6 |
| Prednisone | 14 | $123 | $9 |
| Warfarin | 20 | $122 | $6 |
| Hydrochlorothiazide | 27 | $117 | $4 |
| Alprazolam | 17 | $113 | $7 |
| Spironolactone | 12 | $112 | $9 |
| Losartan | 17 | $111 | $7 |
| Glimepiride | 16 | $103 | $6 |
| Benazepril | 17 | $102 | $6 |
| Diazepam | 23 | $98 | $4 |
| Allopurinol | 11 | $92 | $8 |
| Citalopram Hbr | 12 | $80 | $7 |
| Alendronate | 12 | $72 | $6 |
| Baclofen | 11 | $63 | $6 |
2013: 66 drugs
| Rilutek | 12 | $23,057 | $1,921 |
| Renvela | 18 | $20,977 | $1,165 |
| Lantus | 34 | $11,550 | $340 |
| Modafinil | 25 | $9,981 | $399 |
| Januvia | 40 | $8,889 | $222 |
| Novolog | 33 | $6,264 | $190 |
| Benicar | 47 | $4,709 | $100 |
| Diovan | 24 | $4,459 | $186 |
| Advair Diskus | 14 | $3,848 | $275 |
| Nexium | 23 | $3,534 | $154 |
| Transderm-Scop | 13 | $3,074 | $236 |
| Methenamine Hippurate | 25 | $2,872 | $115 |
| Humalog | 20 | $2,814 | $141 |
| Pradaxa | 12 | $2,503 | $209 |
| Tradjenta | 16 | $1,879 | $117 |
| Potassium Chloride | 56 | $1,680 | $30 |
| Calcium Acetate | 26 | $1,645 | $63 |
| Midodrine | 17 | $1,479 | $87 |
| Hydrocodone-Acetaminophen | 78 | $1,128 | $14 |
| Amlodipine Besylate | 98 | $1,064 | $11 |
| Acarbose | 14 | $860 | $61 |
| Doxycycline Hyclate | 12 | $858 | $71 |
| Clopidogrel | 20 | $774 | $39 |
| Gabapentin | 34 | $748 | $22 |
| Risperidone | 19 | $726 | $38 |
| Levofloxacin | 21 | $696 | $33 |
| Lorazepam | 64 | $657 | $10 |
| Losartan | 14 | $616 | $44 |
| Simvastatin | 52 | $609 | $12 |
| Metoprolol | 16 | $581 | $36 |
| Sucralfate | 12 | $565 | $47 |
| Montelukast | 14 | $561 | $40 |
| Levothyroxine | 44 | $505 | $11 |
| Zolpidem | 24 | $482 | $20 |
| Carbidopa-Levodopa | 15 | $476 | $32 |
| Furosemide | 96 | $453 | $5 |
| Clonazepam | 20 | $452 | $23 |
| Azithromycin | 30 | $438 | $15 |
| Minoxidil | 14 | $437 | $31 |
| Lisinopril | 23 | $422 | $18 |
| Omeprazole | 44 | $419 | $10 |
| Clonidine | 51 | $397 | $8 |
| Atorvastatin | 11 | $350 | $32 |
| Metformin | 33 | $348 | $11 |
| Sodium Chloride | 14 | $323 | $23 |
| Hydroxyzine | 17 | $295 | $17 |
| Spironolactone | 25 | $278 | $11 |
| Paroxetine | 20 | $222 | $11 |
| Benazepril | 33 | $217 | $7 |
| Metoprolol | 31 | $213 | $7 |
| Atenolol | 34 | $203 | $6 |
| Topiramate | 12 | $199 | $17 |
| Pantoprazole | 19 | $194 | $10 |
| Valproic Acid | 16 | $192 | $12 |
| Tamsulosin | 11 | $187 | $17 |
| Alendronate | 21 | $174 | $8 |
| Hydrochlorothiazide | 27 | $156 | $6 |
| Isosorbide Mononitrate Er | 12 | $154 | $13 |
| Benztropine Mesylate | 14 | $148 | $11 |
| Tramadol | 17 | $143 | $8 |
| Chlorthalidone | 12 | $139 | $12 |
| Diazepam | 19 | $117 | $6 |
| Warfarin | 11 | $97 | $9 |
| Fluoxetine | 15 | $96 | $6 |
| Carvedilol | 13 | $89 | $7 |
| Alprazolam | 18 | $57 | $3 |
Money from drug and device companies
$582 in 2025
| 2025 | 12 | 27 | None | $582 |
| 2024 | 13 | 32 | None | $888 |
| 2023 | 12 | 25 | None | $551 |
| 2022 | 12 | 21 | None | $497 |
| 2021 | 8 | 17 | None | $343 |
| 2020 | 5 | 12 | None | $230 |
| 2019 | 6 | 13 | None | $249 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ardelyx | Ibsrela | $145 | 9 payments
|
| Amgen | Krystexxa | $63 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $54 | 2 payments
|
| Akebia Therapeutics | Vafseo | $53 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $53 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $50 | 2 payments
|
See all 27 published payments
| Ardelyx | Meals · 2025-12-09 | Ibsrela | $10 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-02 | Jardiance | $30 |
| Akebia Therapeutics | Meals · 2025-11-18 | Vafseo | $25 |
| Ardelyx | Meals · 2025-10-30 | Ibsrela | $5 |
| Travere Therapeutics | Meals · 2025-10-28 | None | $10 |
| Ardelyx | Meals · 2025-10-27 | Ibsrela | $21 |
| Amgen | Meals · 2025-10-21 | Krystexxa | $33 |
| Lundbeck | Meals · 2025-10-07 | Rexulti | $21 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-30 | Jardiance | $23 |
| Ardelyx | Meals · 2025-09-23 | Ibsrela | $12 |
| Alexion Pharmaceuticals | Meals · 2025-09-16 | Ultomiris | $31 |
| Amgen | Meals · 2025-09-02 | Krystexxa | $15 |
| Ardelyx | Meals · 2025-08-31 | Ibsrela | $19 |
| Ardelyx | Meals · 2025-08-19 | Ibsrela | $24 |
| Lundbeck | Meals · 2025-08-05 | Rexulti | $22 |
| Ardelyx | Meals · 2025-07-21 | Ibsrela | $22 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-16 | Kerendia | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-07-15 | Jynarque | $27 |
| Akebia Therapeutics | Meals · 2025-06-24 | Vafseo | $28 |
| Ardelyx | Meals · 2025-05-26 | Ibsrela | $20 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-13 | Kerendia | $19 |
| Novartis Pharmaceuticals | Meals · 2025-05-01 | None | $29 |
| Ardelyx | Meals · 2025-04-21 | Ibsrela | $12 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-08 | Farxiga | $26 |
| Amgen | Meals · 2025-03-25 | Krystexxa | $15 |
| OPKO Pharmaceuticals | Meals · 2025-02-25 | Rayaldee | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-02-11 | Jynarque | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $888
| Bayer Healthcare Pharmaceuticals | Kerendia | $140 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $137 | 5 payments
|
| GlaxoSmithKline | Arexvy | $133 | 3 payments
|
| Medtronic | Signia | $106 | 1 payment
|
| Ardelyx | Ibsrela | $99 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $86 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $54 | 2 payments
|
| Novartis Pharmaceuticals | None | $30 | 1 payment
|
| Travere Therapeutics | None | $30 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $20 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $19 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $19 | 1 payment
|
| Vifor Pharma | None | $16 | 1 payment
|
2023: $551
| GlaxoSmithKline | Benlysta | $123 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $70 | 4 payments
|
| Travere Therapeutics | None | $53 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $52 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $51 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $42 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $34 | 2 payments
|
| Lilly USA | Mounjaro | $31 | 1 payment
|
| Vifor Pharma | Veltassa | $26 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $24 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $22 | 1 payment
|
| Alexion Pharmaceuticals | None | $22 | 1 payment
|
2022: $497
| Vifor Pharma | Veltassa | $71 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $66 | 2 payments
|
| GlaxoSmithKline | Benlysta | $60 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $52 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $45 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $43 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $37 | 2 payments
|
| Lilly USA | Trulicity | $34 | 1 payment
|
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $25 | 1 payment
|
| Daiichi Sankyo | Injectafer | $24 | 1 payment
|
| Amgen | Parsabiv | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $19 | 1 payment
|
2021: $343
| GlaxoSmithKline | Benlysta | $68 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $49 | 2 payments
|
| Vifor Pharma | Veltassa | $47 | 3 payments
|
| Aurinia Pharma U.S. | Lupkynis | $46 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $45 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $44 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $23 | 1 payment
|
| CMP Pharma | Carospir | $19 | 1 payment
|
2020: $230
| Horizon Therapeutics plc | Krystexxa | $114 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $54 | 3 payments
|
| Novo Nordisk | Saxenda | $23 | 1 payment
|
| Relypsa | Veltassa | $23 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $16 | 1 payment
|
2019: $249
| Horizon Therapeutics plc | Krystexxa | $93 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $55 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $44 | 2 payments
|
| Relypsa | Veltassa | $23 | 1 payment
|
| Mallinckrodt Enterprises | Acthar | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 37.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1518954973
- Licence
- CA A85844California A85844: Current · expires 2028-02-29
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- Po Box 1127, Los Alamitos, CA, 90720
- NPI first listed
- 2005-09-30
- NPI last updated
- 2026-07-30
- NPI record certified
- 2026-07-30
This is when the NPI record was last certified, not a medical board exam.